Showing results (681-690 of 1,144) with videos related to
Sort By:
Pageof 115
Neuropsychopharmacology Reports|February 26, 2025
The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia-Pacific Region: A Cross-Sectional Real-World StudyKeira Herr, Michael Berk, Wei-Lieh Huang, et al.Frontiers in Psychiatry|December 28, 2020
Personality Disorder and Physical Health Comorbidities: A Link With Bone Health?Lana J Williams, Shae E Quirk, Heli Koivumaa-Honkanen, et al.Early Intervention in Psychiatry|July 27, 2021
Not in education, employment and training status in the early stages of bipolar I disorder with psychotic featuresSue M Cotton, Kate M Filia, Martin Lambert, et al.The Australian and New Zealand Journal of Psychiatry|November 22, 2019
Depression in the medically illJoshua D Rosenblat, Paul Kurdyak, Fiammetta Cosci, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 20, 2015
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trialOlivia May Dean, Michael Maes, Melanie Ashton, et al.Journal of Affective Disorders|December 3, 2014
Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorderSandra Odebrecht Vargas Nunes, Luiz Gustavo Piccoli de Melo, Márcia Regina Pizzo de Castro, et al.Behavioural Brain Research|January 2, 2013
Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levelsAdam J Walker, Sandy A Burnett, Kyoko Hasebe, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 9, 2025
The association between hearing impairment and incident depression in older adults: a longitudinal analysisMalcolm P Forbes, Mark W Cox, Katharine Brewster, et al.BMJ Open|September 8, 2025
N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study)Kirsten Morley, Shalini Arunogiri, Jason P Connor, et al.Life Sciences|October 23, 2020
Preventing the development of severe COVID-19 by modifying immunothrombosisGerwyn Morris, Chiara C Bortolasci, Basant K Puri, et al.Pageof 115